Literature DB >> 18805725

Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: importance of G2019S and R1441C mutations in sporadic Parkinson's disease patients.

Gianluca Floris1, Antonino Cannas, Paolo Solla, Maria Rita Murru, Stefania Tranquilli, Daniela Corongiu, Marcella Rolesu, Stefania Cuccu, Claudia Sardu, Francesco Marrosu, Maria Giovanna Marrosu.   

Abstract

Mutations in the LRRK2 gene are the most common known cause of familial and sporadic Parkinson's disease (PD). Few studies performed to date to assess frequency of these mutations are actually only representative of specific areas. Here we study the frequency and clinical phenotype of LRRK2 G2019S, I2020T and R1441C/G/H mutations in 356 Sardinian patients with idiopathic PD and 208 controls. Seventeen additional subjects, relatives of PD mutated probands, were enrolled. Eight patients were mutated in heterozygosis for LRRK2 gene (2.3%): six carried the G2019S (1.7%) and two the R1441C (0.6%) mutation. Three PD patients G2019S carriers (50%) were detected in two contiguous villages comprising 3921 inhabitants while the other three (50%) were identified in the remaining population of 796,079 inhabitants. Only one mutated proband had a family history of PD. LRRK2 G2019S and R1441C mutations associated with PD were not an uncommon mutation in a Sardinian population, especially in sporadic PD patients. The detection of the G2019S variant in ten unaffected relatives confirms a reduced penetrance of the underlying mutation and might explain its prevalence among patients with sporadic PD. These findings may provide new insights into the importance of studies of frequency of LRKK2 mutations in PD patients originating from small ethnically homogeneous populations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18805725     DOI: 10.1016/j.parkreldis.2008.06.009

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  5 in total

1.  Measuring the activity of leucine-rich repeat kinase 2: a kinase involved in Parkinson's disease.

Authors:  Byoung Dae Lee; Xiaojie Li; Ted M Dawson; Valina L Dawson
Journal:  Methods Mol Biol       Date:  2012

Review 2.  The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews.

Authors:  Avner Thaler; Elissa Ash; Ziv Gan-Or; Avi Orr-Urtreger; Nir Giladi
Journal:  J Neural Transm (Vienna)       Date:  2009-11       Impact factor: 3.575

3.  The p.A382T TARDBP gene mutation in Sardinian patients affected by Parkinson's disease and other degenerative parkinsonisms.

Authors:  Antonino Cannas; Giuseppe Borghero; Gian Luca Floris; Paolo Solla; Adriano Chiò; Bryan J Traynor; Andrea Calvo; Gabriella Restagno; Elisa Majounie; Emanuela Costantino; Valeria Piras; Loredana Lavra; Carla Pani; Gianni Orofino; Francesca Di Stefano; Paolo Tacconi; Marcello Mario Mascia; Antonella Muroni; Maria Rita Murru; Stefania Tranquilli; Daniela Corongiu; Marcella Rolesu; Stefania Cuccu; Francesco Marrosu; Maria Giovanna Marrosu
Journal:  Neurogenetics       Date:  2013-04-02       Impact factor: 2.660

4.  Reevaluation of phosphorylation sites in the Parkinson disease-associated leucine-rich repeat kinase 2.

Authors:  Xiaojie Li; Darren J Moore; Yulan Xiong; Ted M Dawson; Valina L Dawson
Journal:  J Biol Chem       Date:  2010-07-01       Impact factor: 5.157

Review 5.  Review of the epidemiology and variability of LRRK2 non-p.Gly2019Ser pathogenic mutations in Parkinson's disease.

Authors:  Paweł Turski; Iwona Chaberska; Piotr Szukało; Paulina Pyska; Łukasz Milanowski; Stanisław Szlufik; Monika Figura; Dorota Hoffman-Zacharska; Joanna Siuda; Dariusz Koziorowski
Journal:  Front Neurosci       Date:  2022-09-20       Impact factor: 5.152

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.